Chair of Biochemical Engineering, Technical University of Munich, Garching, Germany.
Institute of Biotechnology: IBG-1, Forschungszentrum Jülich GmbH, Jülich, Germany.
Bioprocess Biosyst Eng. 2022 Dec;45(12):1939-1954. doi: 10.1007/s00449-022-02797-7. Epub 2022 Oct 28.
Autonomously operated parallelized mL-scale bioreactors are considered the key to reduce bioprocess development cost and time. However, their application is often limited to products with very simple analytics. In this study, we investigated enhanced protein expression conditions of a carboxyl reductase from Nocardia otitidiscaviarum in E. coli. Cells were produced with exponential feeding in a L-scale bioreactor. After the desired cell density for protein expression was reached, the cells were automatically transferred to 48 mL-scale bioreactors operated by a liquid handling station where protein expression studies were conducted. During protein expression, the feed rate and the inducer concentration was varied. At the end of the protein expression phase, the enzymatic activity was estimated by performing automated whole-cell biotransformations in a deep-well-plate. The results were analyzed with hierarchical Bayesian modelling methods to account for the biomass growth during the biotransformation, biomass interference on the subsequent product assay, and to predict absolute and specific enzyme activities at optimal expression conditions. Lower feed rates seemed to be beneficial for high specific and absolute activities. At the optimal investigated expression conditions an activity of [Formula: see text] was estimated with a [Formula: see text] credible interval of [Formula: see text]. This is about 40-fold higher than the highest published data for the enzyme under investigation. With the proposed setup, 192 protein expression conditions were studied during four experimental runs with minimal manual workload, showing the reliability and potential of automated and digitalized bioreactor systems.
自主操作的并行 mL 规模生物反应器被认为是降低生物工艺开发成本和时间的关键。然而,它们的应用通常仅限于具有非常简单分析的产品。在这项研究中,我们研究了来自耳炎诺卡氏菌的羧基还原酶在大肠杆菌中的增强蛋白表达条件。细胞在 L 规模生物反应器中通过指数喂养进行生产。达到所需的蛋白表达细胞密度后,细胞自动转移到由液体处理站操作的 48 mL 规模生物反应器中,在那里进行蛋白表达研究。在蛋白表达过程中,改变了进料速度和诱导剂浓度。在蛋白表达阶段结束时,通过在深孔板中进行自动全细胞生物转化来估计酶活性。使用分层贝叶斯建模方法分析结果,以考虑生物转化过程中的生物量生长、生物量对随后的产物测定的干扰,并预测最佳表达条件下的绝对和比酶活。较低的进料速度似乎有利于高比和绝对活性。在所研究的最佳表达条件下,估计酶活为[Formula: see text],置信区间为[Formula: see text]。这比所研究酶的最高已发表数据高约 40 倍。通过所提出的设置,在四个实验运行中研究了 192 种蛋白表达条件,工作量最小,显示了自动化和数字化生物反应器系统的可靠性和潜力。